Most NEET students spend 80 percent of their preparation time on Human Physiology, Genetics and Ecology. Biotechnology gets pushed to the last two weeks. This is one of the most expensive strategic mistakes a NEET aspirant can make.
Here is the reality. The Biotechnology unit, which covers Chapter 11 (Biotechnology: Principles and Processes) and Chapter 12 (Biotechnology and Its Applications) from Class 12 NCERT, contributed 11 questions and 44 marks to NEET 2021. Even in a relatively lighter year like 2024, it gave 7 questions and 28 marks. That is more than Ecology, more than Reproduction, and nearly as much as Genetics in several years.
More importantly, 6 out of the 10 major sub-topics in this unit are rated easy difficulty. This means the marks are not hard to get. They are simply hard to hold on to if you have not prepared the chapter with the precision it demands. This NEET 2026 Biotechnology guide covers both chapters completely, with NCERT biotechnology class 12 NEET alignment, PYQ analysis from 2010 to 2025, common mistakes and a topper strategy built from real exam patterns. Read it once alongside your NCERT. It will be the most productive three hours of your Biotechnology preparation.
Why Biotechnology Is the Easiest 36-Mark Unit in NEET Biology
Before getting into the theory, understand exactly what is at stake here. The table below shows how many questions NEET has asked from the Biotechnology unit every year for the last seven years.
The average across these seven years is 7.9 questions per year, which translates to approximately 31 marks. In two of these years (2021 and 2022), the chapter gave more than 40 marks by itself.
Now look at the difficulty profile of the sub-topics.
Six out of ten sub-topics are rated Easy. That means a student who reads this chapter thoroughly and solves the PYQs in this guide can realistically target 24 to 32 marks from this unit alone. Leaving Biotechnology under-prepared is not a time-saving decision. It is a marks-losing decision.
Recombinant DNA Technology NEET: Tools, Steps and Processes You Cannot Skip
Recombinant DNA technology is the foundation of everything that comes after it in this chapter. Insulin production, gene therapy, Bt crops and transgenic animals all use the same core toolkit. If the tools are clear, the applications become logical rather than memorised. This section covers each tool at the depth NEET actually tests.
Recombinant DNA technology means joining DNA from two different sources, usually two different organisms, to create a new DNA molecule that does not exist in nature. This recombinant DNA is then introduced into a host organism, which expresses the new gene and produces a new protein. The entire pharmaceutical and agricultural biotechnology industry runs on this one principle.
Restriction Enzymes: Molecular Scissors That Cut DNA at Specific Sites
Restriction enzymes are proteins produced by bacteria as a defence against foreign DNA, particularly bacteriophage DNA. They cut DNA at specific short sequences called recognition sequences. Each restriction enzyme recognises one particular sequence and cuts both strands of the DNA at or near that sequence. This is why they are called molecular scissors.
There are three types of restriction enzymes: Type I, Type II and Type III. NEET focuses exclusively on Type II restriction enzymes because they cut DNA within or very close to the recognition sequence, making them precise and useful for genetic engineering. Type I and Type III cut DNA at sites away from the recognition sequence and are therefore not used in rDNA technology. This distinction between types is directly tested in NEET.
The recognition sequences for restriction enzymes are palindromic. A palindromic sequence reads the same on both strands when read in the 5-prime to 3-prime direction. For example, EcoRI recognises the sequence GAATTC on one strand and the complementary strand reads CTTAAG, but when read 5-prime to 3-prime it also reads GAATTC. This palindromic nature allows the enzyme to bind symmetrically to the double helix and cut both strands.
When EcoRI cuts at its recognition site, it does not cut both strands at the same position. It cuts the two strands at slightly offset positions, leaving short single-stranded overhangs on each cut end. These overhangs are called sticky ends or cohesive ends. Sticky ends are important because they can form hydrogen bonds with complementary sticky ends on another DNA fragment that was cut by the same restriction enzyme. This is how foreign DNA is joined into a vector.
Some restriction enzymes cut both strands at exactly the same position, leaving no overhangs. These ends are called blunt ends. Blunt-end ligation is less efficient than sticky-end ligation but is possible with the enzyme ligase.
Three restriction enzymes appear most often in NEET questions and must be memorised precisely.
NEET has asked questions about EcoRI recognition sequence, about which type of restriction enzyme is used in rDNA technology (Type II), about what palindromic sequences are, and about the difference between sticky ends and blunt ends. All four of these fact categories appear in the table and explanation above.
The enzyme that joins the cut ends together is called DNA ligase. Once the foreign gene is inserted into the vector DNA at the cut site, DNA ligase seals the nicks in the sugar-phosphate backbone to create a continuous recombinant DNA molecule. Without ligase, the rDNA construct would fall apart.
Vectors in Recombinant DNA Technology: Plasmids, Bacteriophages and What NEET Tests
A vector is a DNA molecule that is used to carry the foreign gene into the host cell. The vector must be able to replicate inside the host cell so that the foreign gene is also copied and expressed. Not every DNA molecule can serve as a vector. A good vector must have specific properties.
The four properties of an ideal vector are as follows. First, it must have an origin of replication (ori) so that it can replicate inside the host independently of the host chromosome. Second, it must have one or more restriction enzyme recognition sites where the foreign gene can be inserted. Third, it must have a selectable marker, usually an antibiotic resistance gene, so that transformed cells (those that have taken up the vector) can be identified and selected from non-transformed cells. Fourth, it must be small enough to be introduced into host cells efficiently.
The most commonly used vector in NEET questions is the plasmid pBR322. This was one of the first artificial plasmids designed specifically for cloning. Its name comes from Bolivar and Rodriguez, the scientists who constructed it. The “322” is simply a serial number.
pBR322 has the following components that NEET directly tests.
Insertional inactivation is the key concept from pBR322 that NEET tests directly. If the foreign gene is inserted into the tetR gene of pBR322 by cutting at a restriction site within tetR, the tetracycline resistance gene is disrupted. Bacteria that have taken up this recombinant plasmid will be sensitive to tetracycline but resistant to ampicillin. Bacteria that have taken up a non-recombinant plasmid (one where no insert was added) will be resistant to both ampicillin and tetracycline. This difference in antibiotic sensitivity is how recombinant colonies are identified. NEET 2018 and NEET 2020 both tested insertional inactivation as a direct question.
Beyond plasmids, other vectors used in cloning include bacteriophages (lambda phage), cosmids, bacterial artificial chromosomes (BAC) and yeast artificial chromosomes (YAC). The key difference between these vectors is the size of DNA insert they can carry. Plasmids carry inserts up to 10 kilobases. BACs carry 100 to 300 kilobases. YACs can carry inserts up to 1000 kilobases (1 megabase). For NEET, the most important comparison is between plasmids (small insert capacity) and YACs (largest insert capacity), used in large genome projects like the Human Genome Project.
For plant genetic engineering, a special vector is used called the Ti plasmid from the bacterium Agrobacterium tumefaciens. Agrobacterium naturally infects plants and inserts a piece of its own DNA (called T-DNA) into the plant’s chromosomes, causing a tumour called a crown gall. Scientists have engineered this Ti plasmid by removing the tumour-causing genes and replacing them with the gene of interest. The modified Ti plasmid then acts as a natural delivery system for inserting foreign genes into plant cells. This is how most genetically modified crop plants are created. NEET has tested the Ti plasmid in the context of plant genetic transformation.
PCR: Polymerase Chain Reaction Steps Explained for NEET
PCR was invented by Kary Mullis in 1983, for which he received the Nobel Prize in Chemistry in 1993. PCR allows scientists to make millions of copies of a specific DNA sequence in just a few hours, starting from an extremely small sample. Even a single molecule of DNA can be amplified to produce enough copies for analysis. This has applications in molecular diagnosis, forensic science and research.
Read Related Blog NEET Organic Chemistry 2026 Chapter-wise Topics, Key Reactions and Preparation Strategy
For NEET, you need to understand PCR at two levels. First, the three steps of each cycle. Second, the specific components required and why each is necessary.
The three steps of one PCR cycle are as follows.
Step one is denaturation. The reaction mixture is heated to approximately 94 degrees Celsius. At this temperature, the hydrogen bonds between the two strands of the DNA double helix break and the two strands separate. You now have two single-stranded DNA templates.
Step two is annealing. The temperature is reduced to approximately 40 to 60 degrees Celsius, depending on the primers being used. Short single-stranded DNA sequences called primers attach to the complementary sequences on either side of the target region on each template strand. Primers define exactly which region of the DNA will be amplified. Without primers, DNA polymerase has no starting point.
Step three is extension. The temperature is raised to approximately 72 degrees Celsius, which is the optimal temperature for Taq polymerase. Taq polymerase is a heat-stable DNA polymerase isolated from the thermophilic bacterium Thermus aquaticus, which lives in hot springs. Taq polymerase starts from the 3-prime end of each primer and synthesises a new DNA strand complementary to the template, moving in the 5-prime to 3-prime direction. At the end of this step, the original single-stranded template now has a new complementary strand.
Each completed cycle doubles the number of copies. After 30 cycles, the original two copies of DNA have become over one billion copies. This exponential amplification is what makes PCR so powerful.
The reason Taq polymerase is used specifically, and not a standard DNA polymerase like E. coli DNA polymerase, is that Taq polymerase is not denatured at 94 degrees Celsius. A normal polymerase would be destroyed in the denaturation step and would need to be added fresh at every cycle, making the process impractical. NEET has tested “why is Taq polymerase used in PCR?” The answer is its heat stability.
PCR is used in molecular diagnosis to detect HIV infection even before the patient develops antibodies. Standard HIV tests detect antibodies (which appear weeks after infection). PCR can detect the viral RNA/DNA directly, making it possible to diagnose HIV much earlier. This application of PCR in early diagnosis connects this section to the medicine applications H2 that follows.
Gel Electrophoresis: How DNA Is Separated and Visualised
After restriction enzymes cut DNA into fragments, scientists need a way to separate these fragments by size and visualise them. Gel electrophoresis does exactly this.
The principle of gel electrophoresis is based on two facts about DNA. First, DNA is negatively charged due to the phosphate groups in its backbone. Second, smaller molecules move through a porous gel matrix more easily than larger molecules. Combining these two facts: when an electric current is applied across a gel with DNA samples loaded at one end, the negatively charged DNA moves toward the positive electrode. Smaller fragments travel faster and farther. Larger fragments travel slower and less far. The result is a separation of fragments by size.
The gel used is agarose, which is a polysaccharide extracted from seaweed. Agarose gel has a porous structure that acts as a molecular sieve. The pore size can be adjusted by changing the agarose concentration. Higher agarose concentration means smaller pores, which separates small fragments better. Lower concentration separates large fragments better.
The separated DNA fragments are invisible under normal light. To visualise them, the gel is stained with ethidium bromide, a dye that inserts between the base pairs of DNA (a process called intercalation) and fluoresces bright orange when exposed to ultraviolet light. Under UV illumination, each band of DNA in the gel becomes visible as a glowing orange band. The position of each band tells you the size of the fragment (compared to a size marker run alongside the samples).
The pattern of bands produced from a sample is called a DNA fingerprint when it is used for identification purposes. The gel electrophoresis result from restriction digestion of a person’s DNA produces a unique banding pattern because every person’s DNA sequence is unique. This is the basis of forensic DNA analysis. NEET does not test forensic applications in depth but has tested gel electrophoresis principles in the context of rDNA technology and Southern blotting.
After visualisation, specific DNA bands can be cut out of the gel and the DNA extracted for further use. This eluted DNA is used in downstream cloning steps.
NEET Biology Chapter-wise Previous Year Questions With Answers and Explanations
Biotechnology Applications in Medicine: NEET Notes with PYQs
Before biotechnology, treating a diabetic patient with insulin meant injecting insulin extracted from the pancreas of pigs or cattle. The insulin worked, but not perfectly. Animal insulin differs from human insulin by a few amino acids. A significant number of patients developed immune reactions to it over time. The body recognised animal insulin as foreign and began producing antibodies against it. Getting enough insulin from animal sources was also an increasingly expensive and logistically difficult problem as the number of diabetic patients worldwide grew.
Recombinant DNA technology solved both problems at once. Scientists could now take the gene for human insulin, insert it into bacteria, and produce unlimited quantities of insulin that is structurally identical to the insulin your body makes naturally. No immune reactions. No supply shortage. No dependence on animal slaughter. This single application of biotechnology in medicine has saved and extended millions of lives. It is also one of the most directly tested topics in the NEET Biotechnology chapter.
Insulin Production Using Recombinant DNA Technology: Complete NEET Notes
Human insulin is made of 51 amino acids arranged into two polypeptide chains. Chain A has 21 amino acids. Chain B has 30 amino acids. In the human body, insulin is initially synthesised as a larger precursor molecule called pre-pro-insulin, which is processed to pro-insulin, which is then processed to mature insulin by removing a connecting peptide called the C-peptide. The mature insulin has Chain A and Chain B linked together by two disulfide bonds.
The challenge for producing insulin using bacteria was that bacteria cannot process pro-insulin the same way the human pancreatic beta cells do. Early attempts to express the full insulin gene in E. coli failed to produce properly folded, functional insulin efficiently. The solution that Eli Lilly developed in 1982 was elegant in its simplicity.
The approach works as follows. Two separate DNA sequences were chemically synthesised in the laboratory, one corresponding to Chain A and one corresponding to Chain B of human insulin. These are synthetic genes, designed based on the amino acid sequence of insulin and back-translated into DNA using the genetic code. Importantly, these genes were designed using codons preferred by E. coli, not by human cells, to ensure efficient expression in the bacterial host.
Each synthetic gene was separately inserted into a plasmid vector and introduced into separate cultures of E. coli. One culture of E. coli produced Chain A. A different culture produced Chain B. Each chain was produced in large quantities, harvested by lysing the bacteria, and extracted and purified from the bacterial cell contents.
The two purified chains were then combined in vitro under controlled conditions. Disulfide bonds formed between specific cysteine residues at the correct positions in Chain A and Chain B, producing mature, functional human insulin. The resulting product, branded as Humulin, received FDA approval in 1982 and was the first human therapeutic protein produced by recombinant DNA technology to reach the market.
The critical NEET facts from this entire process are the following.
NEET 2014 asked: “The first human hormone produced by recombinant DNA technology was ?” Answer: Insulin. This is a direct one-liner that appears in NEET papers and mock tests every two to three years. The question sometimes includes growth hormone and thyroxine as distractors. Insulin is the correct answer because it was the first, commercially approved in 1982 before any other recombinant human hormone.
One NEET trap specific to this topic: Some questions ask whether insulin is produced from “natural human insulin gene isolated from pancreatic cells.” The answer is no. Eli Lilly used chemically synthesised DNA sequences corresponding to the A and B chains, not the natural gene isolated from human tissue. This distinction between a synthetic gene and a natural isolated gene has appeared in assertion-reason format in recent mock tests and is expected to appear in NEET 2026.
Gene Therapy for ADA Deficiency: The NEET Question That Appears Every 2 Years
Gene therapy is the process of correcting a genetic disorder by introducing a functional copy of the defective gene into the patient’s cells. It is not about treating the symptoms of the disease. It is about correcting the underlying genetic cause at the DNA level.
To understand why the ADA deficiency case study matters so much for NEET, you first need to understand what ADA deficiency actually does to a child.
Adenosine deaminase (ADA) is an enzyme involved in purine metabolism. Its specific role is to convert adenosine to inosine and deoxyadenosine to deoxyinosine. When ADA is absent or non-functional, deoxyadenosine accumulates in cells. Deoxyadenosine is particularly toxic to lymphocytes, the white blood cells responsible for the immune response. As deoxyadenosine destroys lymphocytes, the affected child has essentially no functional immune system. This condition is called Severe Combined Immunodeficiency (SCID). A child with SCID cannot fight off even ordinary infections. A common cold can be fatal.
The ADA deficiency gene that causes this condition is located on chromosome 20. The gene can be inherited from both parents in a recessive pattern. A child who inherits a defective ADA gene from both parents will have ADA deficiency and SCID.
In 1990, the first clinical gene therapy trial was conducted on a 4-year-old girl with ADA deficiency. This is the most directly tested fact from this entire section in NEET.
The procedure used in 1990 was as follows.
Lymphocytes were extracted from the patient’s blood. A functional copy of the ADA gene was inserted into these lymphocytes using a retroviral vector. Retroviruses are viruses that convert their RNA genome into DNA and integrate it into the host cell’s chromosome. This integration property is exactly what makes retroviruses useful as gene therapy vectors: the therapeutic gene becomes permanently part of the lymphocyte’s chromosome and is expressed as long as that cell lives. The genetically corrected lymphocytes were then infused back into the patient’s body.
The treatment worked. The girl’s ADA levels improved and her immune function was partially restored.
However, this treatment is not a permanent cure. Here is why, and this is the second most tested fact about gene therapy in NEET.
Lymphocytes are mature, differentiated cells. They live for a limited time and are not self-renewing. When the infused corrected lymphocytes eventually die, the patient again has no ADA-producing cells. The treatment therefore requires periodic infusions of corrected lymphocytes to maintain adequate ADA levels.
A truly permanent cure would require introducing the functional ADA gene into the patient’s haematopoietic stem cells, which are self-renewing bone marrow cells that continuously produce new lymphocytes throughout life. A corrected stem cell would produce corrected lymphocytes indefinitely. NEET has asked directly: “What would be a possible permanent cure for ADA deficiency?” The answer is gene introduction into early embryonic cells or bone marrow transplantation.
The complete NEET reference table for gene therapy.
NEET 2016 directly asked: “The first clinical gene therapy was given in 1990 to a 4-year-old girl with ?” Answer: ADA deficiency. Options included X-linked SCID, ADA deficiency, cystic fibrosis and Omenn syndrome. Students who had not studied the exact condition lose this mark. The answer is always ADA deficiency and never X-linked SCID, which is a different disease with a different gene and different history.
Molecular Diagnosis Using PCR and ELISA: NEET Notes
Traditional medical diagnosis relies on detecting the disease after it has already produced symptoms or after a large number of pathogens have accumulated in the body. By this stage, the infection or disease has progressed significantly. Molecular diagnosis changes this by detecting the disease at the DNA or protein level, before symptoms appear and even when pathogen numbers are still extremely low.
Two molecular diagnostic tools are tested in NEET from this section: PCR and ELISA.
PCR in Molecular Diagnosis
The most important application of PCR in molecular diagnosis for NEET is early detection of HIV. The standard HIV test checks for antibodies that the patient’s immune system produces in response to the virus. The problem is that antibodies do not appear immediately after infection. There is a window period of several weeks to a few months during which a person is infected and infectious but the standard antibody test returns negative. This is called the window period.
PCR bypasses this window period entirely. PCR amplifies the viral DNA or RNA sequence directly from the patient’s blood sample. Even if only a few viral particles are present in the blood, PCR can detect and amplify their genetic material to produce a detectable signal. This means HIV can be diagnosed within days of infection, long before any antibody is produced.
The same principle applies to cancer diagnosis. Some cancers are caused by mutations in specific genes. PCR can detect these mutated gene sequences in a patient’s cells before the tumour has grown large enough to cause symptoms or show up on imaging. This is called molecular oncology diagnosis and is an emerging application that NEET has started testing in recent years.
ELISA in Molecular Diagnosis
ELISA stands for Enzyme-Linked Immunosorbent Assay. While PCR detects genetic material (DNA or RNA), ELISA detects proteins, specifically antigens and antibodies. The principle of ELISA is based on the high specificity of antigen-antibody binding.
In a standard ELISA for diagnosis, the patient’s blood serum is exposed to a known antigen bound to a solid surface. If the patient has produced antibodies against that antigen (meaning the patient has been exposed to the pathogen), those antibodies will bind to the antigen. An enzyme-linked secondary antibody is then added, which binds to the patient’s antibodies. When the substrate for the enzyme is added, a colour change occurs. The intensity of the colour is proportional to the amount of antibody present. This colour is measured using a spectrophotometer.
ELISA is used to detect HIV antibodies (after the window period), to screen donated blood for infections, to diagnose dengue, malaria and typhoid, and to detect allergens and hormones.
The NEET distinction between PCR and ELISA must be absolutely clear.
NEET has asked: “Which molecular diagnostic technique is based on antigen-antibody reaction?” Answer: ELISA. And: “Which technique is used to detect HIV before antibody formation?” Answer: PCR. Both questions have appeared as direct one-liners and as part of assertion-reason questions.
Vaccine Production Using Biotechnology: Hepatitis B and Edible Vaccines
A traditional vaccine uses killed or attenuated (weakened) pathogens to stimulate the immune system without causing disease. The limitation of traditional vaccines is that producing large quantities of pathogen, even killed or weakened, carries inherent risk and requires complex biosafety infrastructure. Recombinant DNA technology offers a cleaner alternative: produce only the antigen, not the whole pathogen.
The hepatitis B vaccine is the most important example of a recombinant subunit vaccine for NEET. Hepatitis B is caused by the Hepatitis B virus (HBV). The surface of this virus is covered with a protein called the hepatitis B surface antigen (HBsAg). This antigen is what triggers the immune response. If the immune system recognises HBsAg, it produces antibodies that protect against future hepatitis B infection.
Scientists cloned the gene for HBsAg and expressed it in yeast cells, specifically Saccharomyces cerevisiae (baker’s yeast). The yeast produces large quantities of HBsAg protein, which is harvested, purified and formulated into the hepatitis B vaccine. The resulting vaccine contains no live virus, no killed virus and no viral DNA. It contains only the purified surface antigen protein. This is called a subunit vaccine or recombinant vaccine.
The NEET fact from this topic: Hepatitis B vaccine is produced in yeast (Saccharomyces cerevisiae) using recombinant DNA technology. It is a second-generation vaccine. NEET 2019 asked: “The vaccine for Hepatitis B developed through genetic engineering is a ?” Answer: Second-generation vaccine (recombinant subunit vaccine). First-generation vaccines use killed or attenuated whole pathogens. Second-generation vaccines use recombinant antigens.
Edible vaccines are a concept introduced in NCERT that NEET tests occasionally. The idea is to introduce the gene for a vaccine antigen into food plants like banana or tomato. When the plant is eaten, the antigen is absorbed in the gut and stimulates an immune response. Banana is the most common example given in NCERT for edible vaccines. This concept is still at the experimental stage but appears in NEET as a statement-based question about future biotechnology applications.
A summary table of biotechnology applications in medicine for quick NEET revision.
Biotechnology Applications in Agriculture: Bt Crops, GMOs and RNA Interference NEET 2026
Agriculture is where biotechnology has had its most visible and controversial impact. The goal is straightforward: create crop plants that resist pests, tolerate herbicides, withstand drought, or produce more nutrients, without depending on chemical pesticides that damage soil health, harm non-target organisms and increase farming costs. For NEET, the agricultural applications section has contributed 18 questions on Bt crops alone from 2008 to 2025. It is the most tested application area in the entire Biotechnology unit. The three topics that drive those 18 questions are Bt crops and Cry proteins, RNA interference for nematode resistance, and Golden Rice and other GM crops. Each one is covered here at the level NEET demands.
Bt Cotton and Bt Brinjal: Cry Proteins, Mechanism and NEET PYQs
The name Bt comes from the bacterium Bacillus thuringiensis. This soil bacterium has been known since the early 20th century to be toxic to certain insects. Farmers in some regions used to spray preparations of Bacillus thuringiensis directly onto crops as a biological pesticide. The problem with spraying was that the bacteria did not persist on plants for long, weather washed them away, and the protection was inconsistent. Genetic engineering offered a permanent solution: take the insecticidal gene from Bacillus thuringiensis and insert it directly into the plant’s own genome so every cell of the plant produces the toxin continuously throughout the growing season.
The insecticidal proteins produced by Bacillus thuringiensis are called Cry proteins (crystalline proteins). The genes that encode these proteins are called cry genes. Bacillus thuringiensis produces Cry proteins as part of large, insoluble protein crystals during a specific phase of its growth cycle called sporulation. Inside the bacterium, the Cry protein exists in an inactive form called pro-toxin or protoxin. The pro-toxin is enclosed within these crystal inclusions and is harmless to the bacterium itself and to most organisms.
Here is exactly how the toxin becomes active and kills the insect, and this four-step sequence is directly tested in NEET.
Step one: An insect feeding on a Bt crop plant ingests the pro-toxin crystals along with the plant material.
Step two: The insect’s midgut has an alkaline pH (unlike the acidic stomach pH of mammals). This alkaline environment dissolves the crystal structure, releasing the pro-toxin from its crystal packaging.
Step three: The alkaline pH of the midgut also activates the pro-toxin by cleaving it into its active form. The active toxin is now the functional Cry protein.
Step four: The activated Cry protein binds to specific receptor proteins on the surface of the midgut epithelial cells of the insect. Once bound, it creates pores in the cell membrane. The pores disrupt ion balance inside the cell. Water rushes in through osmosis, the cells swell, the gut lining is destroyed, and the insect stops feeding. The insect eventually dies from starvation and gut destruction.
This is why Bt toxin is insect-specific and not harmful to humans, cattle, birds or other non-target organisms. The alkaline pH activation is the critical condition. The human digestive system is acidic in the stomach (pH 2) and only mildly alkaline in the small intestine. The pro-toxin is not activated to its functional form in the human digestive system. Furthermore, even if small amounts of active toxin were ingested by humans, the specific receptor proteins on insect midgut epithelial cells are not present in mammalian intestinal cells, so the toxin has nothing to bind to and cannot create pores.
The most important NEET trap from this entire mechanism: several NEET questions and mock tests have placed the statement “Bt toxin is activated by acidic pH of the insect gut” as an incorrect statement among the answer options, expecting students to identify it as wrong. The activation happens at alkaline pH, not acidic pH. The insect midgut is alkaline. This is the most commonly tested single fact about Bt toxin in NEET papers from 2015 onwards.
Different cry genes encode different Cry proteins, and different Cry proteins are toxic to different groups of insects. NEET has asked about specific cry genes and which pests they control. The table below covers the exact combinations that have appeared or are likely to appear in NEET 2026.
NEET 2022 directly asked: “The protein products of cry1Ac and cry2Ab genes control which of the following pests?” The answer is cotton bollworm and American bollworm, both lepidopteran pests of cotton. Students who had only memorised that Bt cotton uses cry genes without knowing which specific genes target which pests lost this mark.
Bt Brinjal deserves a separate mention because it carries its own examination and policy significance for NEET. Bt Brinjal was developed by inserting the cry1Ac gene to protect brinjal (eggplant) from fruit and shoot borer, a major pest. India placed a moratorium on commercial release of Bt Brinjal in 2010 pending further biosafety studies. This regulatory decision is connected to the GEAC (Genetic Engineering Appraisal Committee) content covered later in this guide. NEET has used Bt Brinjal in questions about which crop has been modified for insect resistance (NEET 2010 directly asked this).
RNA Interference: How Nematode Resistance Is Created in Plants
RNA interference is a gene-silencing mechanism that exists naturally in most eukaryotic cells. Its natural role is to protect cells from viruses and regulate gene expression. In the context of crop protection, scientists have used RNAi to create plants that silence the genes of parasites living inside them, effectively killing the parasite from within.
The example in NCERT, and the one NEET tests directly, involves the nematode Meloidogyne incognita and tobacco plants.
Meloidogyne incognita is a parasitic nematode that infects the roots of tobacco plants. It penetrates the root tissue, feeds on plant cells, and causes significant yield losses. Unlike insect pests that chew leaves from the outside, this nematode lives inside the root tissue, making it difficult to control with contact pesticides.
The RNAi strategy to control this nematode works as follows.
Scientists identified specific genes in Meloidogyne incognita that are essential for the nematode’s survival. The plan was to silence these genes inside the nematode using RNAi. The challenge was delivering the double-stranded RNA (dsRNA) into the nematode.
The solution was elegant. A DNA construct was prepared that could produce both a sense RNA strand and an antisense RNA strand of the target nematode gene simultaneously. When both strands are present in the same cell, they bind to each other by complementary base pairing, forming a double-stranded RNA (dsRNA) molecule. This dsRNA triggers the RNAi pathway.
This DNA construct was introduced into tobacco plants using Agrobacterium tumefaciens as the vector. The transgenic tobacco plants now produce dsRNA corresponding to the essential nematode gene in their root cells.
When Meloidogyne incognita infects the roots of these transgenic tobacco plants, it ingests the plant cell contents, including the dsRNA produced by the plant. Inside the nematode, the dsRNA enters the RNAi pathway. The dsRNA is processed into small interfering RNAs (siRNAs). The siRNAs guide the RNA-induced silencing complex (RISC) to the complementary mRNA of the target gene in the nematode. The RISC cleaves and degrades the target mRNA. Without the mRNA, the essential protein cannot be produced. Without this essential protein, the nematode cannot survive inside the plant.
The result is a transgenic tobacco plant that is resistant to Meloidogyne incognita through a mechanism that is entirely internal to the plant-nematode interaction, requires no external pesticide application, and is highly specific to the target nematode.
NEET has asked: “RNA interference used to develop resistance against tobacco plant pest involves ?” Answer: Preventing translation of mRNA of the nematode (gene silencing via dsRNA). The key word in the answer is “translation of mRNA of the nematode,” not transcription of plant DNA. RNAi does not change the plant’s DNA or the nematode’s DNA. It silences the expression of the nematode’s gene by degrading its mRNA before translation can occur.
Another NEET PYQ pattern from this topic: “In 2011, RNA interference was used in ?” Answer: Making tobacco plants resistant to Meloidogyne incognita. This appeared as a direct statement matching question. Always remember the specific nematode name (Meloidogyne incognita), the specific plant (tobacco) and the specific vector used to create the transgenic plant (Agrobacterium tumefaciens). All three details have appeared in NEET questions.
Golden Rice and GM Crops: What NEET Actually Tests
Golden Rice is one of the most discussed genetically modified organisms in the world, both in terms of its potential humanitarian value and the ethical debates surrounding it. For NEET, the examination angle is straightforward: know what problem it solves, how it was made, and what specific nutrient it provides.
Vitamin A deficiency is a serious global health problem. It causes night blindness (an inability to see in low light conditions) and in severe cases leads to complete blindness. It is a leading cause of preventable blindness in children in developing countries, including India. The human body synthesises Vitamin A from beta-carotene, a pigment found in orange and yellow vegetables like carrots and pumpkins.
Rice is a staple food for billions of people, particularly in Asia and Africa. Normal white rice contains no beta-carotene in the grain (the endosperm). Rice plants produce beta-carotene in their leaves but the pathway is switched off in the grain itself. The result is that populations that depend heavily on rice as a staple food are at high risk of Vitamin A deficiency.
Golden Rice was developed by Ingo Potrykus and Peter Beyer by inserting two genes into the rice genome that restore beta-carotene synthesis in the grain. The resulting rice has a golden-yellow colour due to the accumulated beta-carotene in the endosperm, which is why it is called Golden Rice. When eaten, the beta-carotene is converted to Vitamin A in the body, providing provitamin A activity. NEET 2008 asked directly: “Golden Rice is developed to solve the problem of ?” Answer: Night blindness (Vitamin A deficiency).
Beyond Golden Rice, NEET tests a few other GM crop examples. Each one has a specific modification and a specific purpose.
Flavr Savr tomato deserves attention because its mechanism uses a concept (antisense RNA) that connects to RNAi. Normal tomatoes produce the enzyme polygalacturonase, which breaks down pectin in cell walls, causing the fruit to soften and rot. In Flavr Savr tomato, an antisense RNA complementary to the polygalacturonase mRNA was introduced. This antisense RNA binds to the polygalacturonase mRNA and prevents its translation, reducing enzyme production and slowing cell wall breakdown. The result is a tomato with a longer shelf life. Flavr Savr was the first commercially released GM food crop, approved in the United States in 1994. NEET occasionally tests which crop was the first commercially released GM crop (Flavr Savr tomato) and the mechanism used (antisense RNA).
Transgenic Animals NEET: Types, Uses and Every Fact the Exam Tests
A transgenic animal is one that has a foreign gene (a gene from another organism) stably integrated into its genome and expressed in one or more of its tissues. The foreign gene is called a transgene. The transgene is present in every cell of the animal because it was introduced at the embryonic stage, before cell differentiation. This means the transgene is heritable: transgenic animals pass the foreign gene to their offspring.
Transgenic animals are different from cloned animals. A cloned animal like Dolly the sheep is genetically identical to its parent but has no foreign gene. A transgenic animal has a foreign gene that does not exist in its natural genome.
The most important single fact about transgenic animals for NEET: the majority of all transgenic animals created worldwide are mice. NEET 2011 directly asked: “Maximum transgenic animals created for research are ?” Answer: Mice. Mice are the preferred research organism because they breed quickly, have small body size (easy to house in large numbers), have a genome that is well characterised, and their physiology is similar to humans in many disease-relevant ways.
Transgenic animals serve five major purposes in science and medicine. Each of these purposes has been tested in NEET.
Purpose 1: Study of Normal Physiology and Development
Transgenic animals allow scientists to study how a gene functions in the context of a living organism. By introducing an extra copy of a gene or a modified version of a gene, scientists can observe what happens to the animal’s development and physiology. For example, introducing extra copies of growth hormone genes into mice produced transgenic mice that grew significantly larger than normal mice. This showed that growth hormone genes directly control body size. This type of transgenic experiment is called gain-of-function analysis.
Purpose 2: Study of Disease Models
Many human genetic diseases can be studied by creating transgenic mice that carry the human disease gene. These mice develop symptoms similar to the human disease, providing a controlled model for studying the disease mechanism and testing potential treatments. Transgenic mice have been created as models for Alzheimer’s disease, cystic fibrosis, cancer, diabetes and heart disease. The oncomouse (also called Harvard Mouse) was a transgenic mouse created to develop cancer, used as a model for cancer research. It was the first transgenic animal to be patented in the United States (1988). NEET has tested the oncomouse in the context of transgenic disease models.
Purpose 3: Biological Products for Medicine
Transgenic animals can be engineered to produce valuable human proteins in their milk, blood or urine. The most scalable system is milk production because cows, goats and sheep produce large volumes of milk and the protein can be easily harvested.
Rosie was the first transgenic cow, created in 1997. Rosie produced human protein-enriched milk at a rate of 2.4 grams of human alpha-lactalbumin per litre of milk. Alpha-lactalbumin is a protein found in human breast milk that is important for infant nutrition and immune development. Normal cow milk has low alpha-lactalbumin. Rosie’s milk was nutritionally more balanced for human babies than ordinary cow milk.
The NEET assertion-reason trap on Rosie: NEET has presented an assertion “Rosie’s milk was nutritionally more balanced for human babies” (TRUE) paired with a reason “Rosie’s milk contained alpha-1-antitrypsin used to treat emphysema” (FALSE for Rosie specifically). Alpha-1-antitrypsin is produced by transgenic sheep for treating emphysema, not by Rosie. Rosie produced alpha-lactalbumin. These are two different proteins from two different transgenic animals. NEET has specifically tested this distinction in assertion-reason format.
Another important example: transgenic sheep and goats have been engineered to produce alpha-1-antitrypsin, a human protein that protects lung tissue from damage by neutrophil elastase. People with a genetic deficiency of alpha-1-antitrypsin develop emphysema, a condition where lung tissue is progressively destroyed. Producing alpha-1-antitrypsin from transgenic animals provides a source for treating this condition.
Purpose 4: Vaccine Safety Testing
Before a new vaccine is tested on humans, it must be tested for safety in animals. Polio vaccine was traditionally tested in monkeys, which are expensive to maintain and raise ethical concerns. Transgenic mice that express the human poliovirus receptor have been created. These mice can be infected with poliovirus and respond similarly to humans. Testing polio vaccine safety in these transgenic mice is cheaper, faster and produces results more relevant to human response than testing in non-transgenic animals.
Purpose 5: Chemical Safety Testing
Transgenic animals are used in toxicity testing of chemicals, drugs and environmental pollutants. These animals have been made more sensitive to toxic substances by introducing genes that increase the biological response to toxins. A chemical that might require years of exposure to cause detectable harm in a normal animal can cause detectable harm much faster in a sensitised transgenic animal. This makes testing of industrial chemicals and pharmaceutical compounds faster and more reliable.
A summary table for quick transgenic animals revision before NEET.
| Transgenic Animal | Transgene Introduced | Product or Purpose | NEET Point |
|---|---|---|---|
| Rosie (cow, 1997) | Human alpha-lactalbumin gene | Protein-enriched milk for human infants | Most tested transgenic animal after mice |
| Transgenic sheep and goat | Human alpha-1-antitrypsin gene | Treatment of emphysema | Commonly confused with Rosie in NEET traps |
| Oncomouse (mouse, 1988) | Activated cancer gene | Cancer research model | First patented transgenic animal |
| Mice (disease models) | Various human disease genes | Models for Alzheimer’s, diabetes, cystic fibrosis | Maximum transgenic animals are mice (NEET 2011) |
| Transgenic mice (vaccine testing) | Human poliovirus receptor | Polio vaccine safety testing | Alternative to monkey testing |
NEET Dropper Year Plan 2026 — The Complete Month-by-Month Strategy to Go From Last Attempt to MBBS
Biosafety, Biopiracy and Patents: The Ethics Section NEET Tests Every 3 Years
This section of the Biotechnology chapter deals with the ethical, legal and environmental questions raised by genetic engineering and the commercial use of biological resources. Students often skip it because it feels less scientific than the rest of the chapter. That is a mistake. This section generates one question every three years with a high probability, it is entirely factual with no calculations or diagrams required, and the marks are genuinely free for any student who reads these two NCERT pages carefully.
GEAC: India’s Regulatory Body for Genetically Modified Organisms
GEAC stands for Genetic Engineering Appraisal Committee. It functions under the Ministry of Environment, Forest and Climate Change, Government of India. Its role is to approve large-scale use of living modified organisms (GMOs) and the safety of introducing GMOs for research and commercial release in India.
Without GEAC approval, no GMO can be commercially released in India for agricultural or environmental use. GEAC approved Bt cotton for commercial cultivation in India in 2002, making it the first GM crop to receive commercial approval in the country. GEAC placed a moratorium on commercial release of Bt Brinjal in 2010, pending further independent safety studies. Both decisions are NEET-relevant because NEET has connected GEAC to these specific crops in statement-based questions.
For NEET, the facts to remember about GEAC are as follows: its full form (Genetic Engineering Appraisal Committee), which ministry it falls under (Ministry of Environment), and its authority (approves or rejects commercial GMO release in India).
Biopiracy and Patents: Turmeric, Neem and Basmati Cases for NEET
Biopiracy is the use of biological resources, including genetic material and traditional knowledge associated with those resources, without appropriate authorisation from and fair compensation to the communities that have developed and preserved that knowledge over generations. It is essentially the commercial exploitation of a community’s biological heritage by outside corporations, often through the patent system.
India has been at the centre of several high-profile biopiracy cases. Three cases appear in NEET and must be known in detail.
The Turmeric Case: In 1995, the United States Patent and Trademark Office granted a patent to two scientists at the University of Mississippi Medical Center for “the use of turmeric in wound healing.” The problem was that turmeric has been used in India for wound healing for thousands of years and this use is extensively documented in ancient Sanskrit texts. The Council of Scientific and Industrial Research (CSIR) of India challenged this patent, providing documentary evidence from ancient Indian texts that proved prior art. The patent was revoked in 1997. This was one of the first successful challenges to a biopiracy patent and established the importance of documenting traditional knowledge.
The Neem Case: A European patent was granted to the US Department of Agriculture and the multinational corporation W.R. Grace for a method of using neem oil as a fungicide. Use of neem for pest control and as a fungicide has been documented in Indian agriculture for centuries. The patent was challenged by the Indian government and international organisations. The European Patent Office revoked the patent in 2000 after examining evidence of traditional prior use.
The Basmati Case: The US company RiceTec was granted a patent in 1997 for “Basmati rice lines and grains.” This patent covered certain Basmati varieties and the grain characteristics of Basmati rice. India protested vigorously, arguing that Basmati is a traditional variety developed by Indian and Pakistani farmers over generations. Following sustained legal challenge, most of the controversial claims of the RiceTec patent were cancelled by the US Patent and Trademark Office.
The international legal framework for preventing biopiracy is the Convention on Biological Diversity (CBD), which recognises the sovereign rights of nations over their biological resources and requires sharing of benefits arising from their commercial use with the source communities. India enacted the Biological Diversity Act in 2002 to implement the CBD domestically and to protect Indian biological resources and associated traditional knowledge from exploitation.
For NEET, the questions on biopiracy appear in two formats. Direct questions ask for the definition or an example of biopiracy. Statement-based questions present a scenario and ask whether it constitutes biopiracy. The three Indian cases above cover every scenario that has appeared in NEET from this sub-topic.
Biotechnology NEET PYQ Analysis: Year-Wise Table 2015 to 2025
This table maps every confirmed NEET question from the Biotechnology unit from 2015 to 2025. Use it as a revision checklist. Any concept that appears more than twice in this table is a confirmed high-priority topic that you must be able to answer in under 20 seconds.
Most Important Biotechnology Sub-Topics Ranked by PYQ Frequency
This ranked list is built from 17 years of NEET PYQ data (2008 to 2025). The rank tells you where to direct your revision time. Do not start from Rank 10 and work backwards. Start from Rank 1.
What this ranking tells you concretely: Ranks 1 to 4 alone account for 68 questions across 17 years. These four sub-topics generate 4 marks from Biotechnology in almost every NEET paper. A student who masters only these four sub-topics at full PYQ depth is already positioned to score 16 marks from this chapter with minimal effort. Add Ranks 5 to 8 and you are looking at 32 marks from a chapter most students treat as secondary.
NEET Dropper Mental Health — The Complete Guide to Managing Anxiety, Burnout and Depression During Your Drop Year
Common Mistakes Students Make in Biotechnology NEET Questions
Every mistake below has been responsible for wrong answers in actual NEET papers or in mock tests that replicate NEET patterns. Correct each one before your exam.
Mistake 1: Saying Bt toxin is activated by acidic pH
This is the single most expensive error in Biotechnology NEET preparation. The insect midgut is alkaline. The alkaline pH dissolves the crystal and activates the pro-toxin. A human stomach is acidic. The pro-toxin is NOT activated in a human digestive system. NEET 2015 and multiple subsequent mock tests have used the wrong statement “activated by acidic pH of insect gut” as a trap. Every time you read “acidic” in a Bt toxin question, mark it as wrong.
Correction: Bt pro-toxin is activated by the alkaline pH of the insect midgut. Alkaline. Not acidic.
Mistake 2: Confusing alpha-lactalbumin (Rosie) with alpha-1-antitrypsin (transgenic sheep)
Rosie the cow produced human alpha-lactalbumin to enrich milk for human infants. Transgenic sheep produced human alpha-1-antitrypsin to treat emphysema. These are two different proteins, from two different transgenic animals, for two completely different purposes. NEET has tested this in assertion-reason format where the reason states the wrong protein for Rosie.
Correction: Rosie = cow = alpha-lactalbumin = infant nutrition. Transgenic sheep = alpha-1-antitrypsin = emphysema treatment.
Mistake 3: Writing that rDNA insulin uses the natural human insulin gene
Eli Lilly used chemically synthesised DNA sequences, not the natural insulin gene isolated from human pancreatic cells. This is because bacteria cannot process introns, and the natural human insulin gene contains introns. The synthetic genes were designed using only the coding sequence (based on the amino acid sequence of insulin) with codons optimised for E. coli expression.
Correction: Eli Lilly used synthetic DNA sequences corresponding to Chain A and Chain B of insulin, separately synthesised and introduced into separate E. coli cultures.
Mistake 4: Saying the first gene therapy used a plasmid vector
The 1990 ADA deficiency gene therapy used a retroviral vector, not a plasmid. Retroviruses were chosen because they can integrate their genetic material (and thus the therapeutic gene) permanently into the host lymphocyte’s chromosome. A plasmid would not integrate and would be lost when the lymphocyte divides.
Correction: Gene therapy for ADA deficiency used a retroviral vector that integrates the functional ADA gene into the lymphocyte chromosome.
Mistake 5: Assuming gene therapy for ADA deficiency is a permanent cure
It is not permanent. Lymphocytes are terminally differentiated cells that do not self-renew. Once the corrected lymphocytes die, the patient again lacks ADA. The patient requires periodic infusions of freshly corrected lymphocytes. The permanent solution would require correcting haematopoietic stem cells in bone marrow, which are self-renewing.
Correction: Gene therapy for ADA using lymphocytes is NOT permanent. Permanent cure requires bone marrow stem cell correction.
Mistake 6: Misidentifying the organism for Hepatitis B vaccine production
Hepatitis B vaccine is produced in Saccharomyces cerevisiae (baker’s yeast). It is NOT produced in E. coli. The distinction matters because the hepatitis B surface antigen (HBsAg) requires post-translational glycosylation that bacteria cannot perform but yeast can. NEET has used E. coli as a distractor option in Hepatitis B vaccine questions.
Correction: Hepatitis B vaccine = yeast (Saccharomyces cerevisiae), not E. coli.
Mistake 7: Saying larger DNA fragments travel farther in gel electrophoresis
In gel electrophoresis, smaller DNA fragments travel farther because they can move more easily through the pores of the agarose gel. Larger fragments are physically impeded by the gel matrix and travel a shorter distance from the loading well in the same time. Students who confuse “more current = faster movement” with fragment size get this backwards.
Correction: Smaller fragments = travel farther from the loading well. Larger fragments = travel less far and remain closer to the loading well.
Mistake 8: Saying maximum transgenic animals are sheep or cattle
The majority of all transgenic animals created worldwide are mice. Not sheep. Not cattle. Not goats. Mice dominate because of their small size, fast breeding, short lifespan, well-mapped genome, and physiological similarity to humans for research purposes. NEET 2011 asked this directly. The answer is always mice.
Correction: Maximum transgenic animals = mice. This is a direct NEET PYQ fact.
Mistake 9: Confusing the RNAi target organism with the plant host
In the tobacco-Meloidogyne incognita RNAi experiment, the RNAi construct is inside the plant (tobacco). The silencing affects the nematode’s gene, not the plant’s gene. Students who read this section quickly sometimes answer that the plant’s gene was silenced. The plant’s own genes are unaffected. Only the nematode’s gene is silenced because only the nematode ingests the dsRNA produced by the plant.
Correction: RNAi in transgenic tobacco silences the nematode’s (Meloidogyne incognita’s) essential gene, not a tobacco plant gene.
Mistake 10: Saying Type I restriction enzymes are used in rDNA technology
Only Type II restriction enzymes are used in recombinant DNA technology because they cut DNA within or very close to the recognition sequence, giving precise, predictable cuts. Type I and Type III enzymes cut at sites far from the recognition sequence, producing unpredictable fragments that cannot be reliably used for cloning.
Correction: Only Type II restriction enzymes are used in genetic engineering and rDNA technology.
Mistake 11: Writing the turmeric patent was revoked in 1995
The turmeric patent was granted in 1995. CSIR challenged it and the patent was revoked in 1997. Two years separate the grant and the revocation. NEET has tested the year of revocation in statement-based questions where one statement gives the correct year and another gives an incorrect year. The patent was revoked in 1997, not 1995.
Correction: Turmeric patent granted 1995. Revoked 1997. These are two different years and both may appear in NEET questions.
Mistake 12: Treating ELISA and PCR as interchangeable diagnostic tools
PCR detects genetic material (DNA or RNA) and is used before antibodies form (during the HIV window period). ELISA detects antigens or antibodies (proteins) and is used after antibody formation. They detect fundamentally different things using fundamentally different principles. A question asking “which method detects HIV before antibodies are produced?” expects PCR, not ELISA. A question asking “which method is based on antigen-antibody reaction?” expects ELISA, not PCR.
Correction: PCR = detects nucleic acid = early HIV detection. ELISA = detects protein (antigen or antibody) = post-window period HIV antibody detection.
15 NEET-Style Practice MCQs on Biotechnology with Full Solutions
Work through all 15 questions without looking at the answers. Score yourself. Any question you get wrong points to an exact revision target in this guide.
Q1. The palindromic recognition sequence of EcoRI is:
(A) 5-GGATCC-3 (B) 5-AAGCTT-3 (C) 5-GAATTC-3 (D) 5-CCTAGG-3
Answer: (C) 5-GAATTC-3. EcoRI recognises GAATTC. BamHI recognises GGATCC (option A). HindIII recognises AAGCTT (option B). CCTAGG is not a restriction enzyme recognition sequence given in NCERT. Memorise all three as a set because NEET frequently uses two or three of them as options in the same question.
Q2. In pBR322, a foreign gene is inserted into the BamHI site within the tetracycline resistance gene. Bacteria that have taken up this recombinant plasmid will be:
(A) Resistant to both ampicillin and tetracycline
(B) Sensitive to both ampicillin and tetracycline
(C) Resistant to ampicillin but sensitive to tetracycline
(D) Sensitive to ampicillin but resistant to tetracycline
Answer: (C) Resistant to ampicillin but sensitive to tetracycline. The foreign gene disrupts the tetR gene (insertional inactivation), so the bacteria lose tetracycline resistance. The ampR gene is untouched, so ampicillin resistance remains. This is the standard NEET insertional inactivation question format.
Q3. The first human hormone produced by recombinant DNA technology was:
(A) Thyroxine (B) Growth hormone (C) Insulin (D) Glucagon
Answer: (C) Insulin. Eli Lilly produced the first commercially approved recombinant human protein, Humulin (insulin), in 1982. This is a direct NEET 2014 PYQ pattern. Thyroxine is not a protein hormone and cannot be produced by rDNA. Growth hormone was produced by rDNA later than insulin.
Q4. In the production of human insulin by Eli Lilly, chains A and B were:
(A) Isolated from human pancreatic cells separately
(B) Produced together in one E. coli culture
(C) Produced separately in two different E. coli cultures, then combined
(D) Produced in yeast and then combined
Answer: (C) Produced separately in two different E. coli cultures, then combined. Synthetic genes for Chain A and Chain B were introduced into separate E. coli cultures. The purified chains were combined in vitro to form active insulin. This is the NEET trap that tests whether students know the synthetic gene approach versus a natural gene isolation approach.
Q5. Bt pro-toxin becomes active in the insect gut because of:
(A) Acidic pH of insect stomach
(B) Alkaline pH of insect midgut
(C) Neutral pH of insect haemolymph
(D) Low temperature of insect midgut
Answer: (B) Alkaline pH of insect midgut. The alkaline pH dissolves the crystal structure and activates the pro-toxin. This question appeared in NEET 2015 and has appeared in mock tests almost every year since. Option A is the most dangerous wrong answer because students confuse insect midgut pH with human stomach pH.
Q6. The cry genes used to develop Bt cotton that resist cotton bollworm and American bollworm are:
(A) cry1Ab and cry3A (B) cry1Ac and cry2Ab (C) cry3A and cry2Ab (D) cry1Ac and cry1Ab
Answer: (B) cry1Ac and cry2Ab. cry1Ac targets cotton bollworm (Lepidoptera), cry2Ab targets American bollworm (Lepidoptera). This was tested directly in NEET 2022. cry3A targets Coleopteran pests (beetles) in potato. cry1Ab is used in Bt maize against stem borer.
Q7. The first clinical gene therapy in 1990 was carried out on a 4-year-old girl suffering from:
(A) Cystic fibrosis (B) Sickle cell anaemia (C) ADA deficiency (D) X-linked SCID
Answer: (C) ADA deficiency. This is NEET 2016 PYQ. The child had adenosine deaminase deficiency, which caused Severe Combined Immunodeficiency. X-linked SCID is a different genetic condition caused by a mutation in a different gene and was the target of a different gene therapy trial (1999 in France). Cystic fibrosis and sickle cell anaemia have been investigated for gene therapy but neither was the 1990 first trial.
Q8. Gene therapy for ADA deficiency using lymphocytes is not a permanent cure because:
(A) Retroviral vectors are not stable in lymphocytes
(B) The ADA gene is not expressed in lymphocytes
(C) Lymphocytes are non-renewing cells that eventually die
(D) The treatment causes severe immune reactions
Answer: (C) Lymphocytes are non-renewing cells that eventually die. Once the corrected lymphocytes reach the end of their lifespan, the patient again has no ADA-producing cells. The treatment must be repeated periodically. Option A is wrong because retroviral integration is stable. Option B is wrong because ADA is expressed in lymphocytes. Option D has no factual basis.
Q9. Which of the following correctly describes RNA interference used to develop nematode-resistant tobacco plants?
(A) An antisense RNA complementary to nematode rRNA was introduced into tobacco
(B) A dsRNA corresponding to an essential nematode gene was produced in tobacco cells using Agrobacterium
(C) The tobacco plant was engineered to produce Bt toxin against the nematode
(D) Retroviruses were used to insert a silencing gene into nematode DNA directly
Answer: (B) A dsRNA corresponding to an essential nematode gene was produced in tobacco cells using Agrobacterium. Both sense and antisense RNA corresponding to the target nematode gene were expressed in tobacco cells using an Agrobacterium vector. The dsRNA triggers RNAi in the nematode when it feeds on the plant. Bt toxin targets insects, not nematodes. Retroviruses infect animal cells, not nematodes.
Q10. Which of the following is a second-generation (recombinant) vaccine?
(A) Oral polio vaccine (B) BCG vaccine (C) Hepatitis B vaccine (D) Smallpox vaccine
Answer: (C) Hepatitis B vaccine. The hepatitis B vaccine is produced by expressing the HBsAg gene in Saccharomyces cerevisiae and using the purified protein as the vaccine antigen. It contains no live or killed virus. Oral polio, BCG and smallpox vaccines are all first-generation vaccines using attenuated or killed organisms. NEET 2019 directly tested this classification.
Q11. The transgenic cow Rosie produced milk enriched with:
(A) Human alpha-1-antitrypsin (B) Human growth hormone
(C) Human alpha-lactalbumin (D) Human insulin
Answer: (C) Human alpha-lactalbumin. Rosie produced 2.4 grams of human alpha-lactalbumin per litre of milk to make it nutritionally balanced for human infants. Alpha-1-antitrypsin is produced by transgenic sheep and goats for treating emphysema. Insulin is produced in E. coli. Growth hormone is produced in other recombinant systems.
Q12. In gel electrophoresis of DNA fragments, which statement is correct?
(A) Larger fragments travel farther toward the positive electrode
(B) DNA moves toward the negative electrode because it is negatively charged
(C) Ethidium bromide is used to stain DNA and visualised under UV light
(D) Agarose gel is prepared from protein polymers
Answer: (C) Ethidium bromide is used to stain DNA and visualised under UV light. Option A is wrong because smaller fragments travel farther. Option B is wrong because DNA moves toward the positive electrode (DNA is negatively charged and moves toward the positive pole). Option D is wrong because agarose is a polysaccharide extracted from seaweed, not a protein polymer.
Q13. Which of the following Indian biopiracy cases involved a challenge against a US patent on wound healing properties?
(A) Neem case (B) Turmeric case (C) Basmati case (D) Darjeeling tea case
Answer: (B) Turmeric case. In 1995, a US patent was granted for use of turmeric in wound healing. CSIR challenged it and it was revoked in 1997. The neem case involved a fungicidal patent granted by the European Patent Office. The basmati case involved grain characteristics of basmati rice. Darjeeling tea has no NEET biopiracy case associated with it.
Q14. GEAC (Genetic Engineering Appraisal Committee) operates under which Indian ministry?
(A) Ministry of Agriculture and Farmers Welfare
(B) Ministry of Health and Family Welfare
(C) Ministry of Science and Technology
(D) Ministry of Environment, Forest and Climate Change
Answer: (D) Ministry of Environment, Forest and Climate Change. GEAC is empowered to approve large-scale use of living modified organisms and GMO releases for research and commercial purposes in India. Students who confuse it with ICMR (health ministry) or DBT (science ministry) lose this mark. The environment ministry connection makes logical sense because GMO release is primarily an ecological and environmental decision.
Q15. Which of the following techniques can detect HIV infection before the patient has produced any antibodies?
(A) ELISA (B) PCR (C) Southern blotting (D) Immunofluorescence
Answer: (B) PCR. PCR amplifies viral nucleic acid directly and can detect the virus within days of infection, long before antibodies appear. ELISA detects antibodies and therefore requires the window period to elapse before a positive result is possible. Southern blotting is used for detecting specific DNA sequences in genomic DNA and is not a diagnostic test for infection in clinical practice. Immunofluorescence detects proteins using labelled antibodies.
NEET vs JEE — Which is Harder? The Most Honest Comparison You Will Find
Topper Tips: How to Score Full Marks from Biotechnology in NEET 2026
Tip 1: Learn Biotechnology as One Connected Story, Not as Ten Separate Facts
Every topic in Biotechnology connects to the same underlying logic: cut the gene, carry it in a vector, insert it into a host, express it, and use the product. Restriction enzymes cut the gene. Vectors carry it. Gel electrophoresis checks the cut. PCR amplifies it. The host (E. coli, yeast, transgenic animal, crop plant) expresses it. The product treats disease (insulin, alpha-1-antitrypsin), fights pests (Cry protein in Bt crops), or provides nutrition (Golden Rice). When you understand this flow, every application chapter topic becomes a logical consequence of the principles chapter, not a separate set of facts to memorise.
Tip 2: The Alkaline pH Fact Is Worth One Free Mark in Almost Every NEET Paper
This one fact, that Bt pro-toxin is activated by the alkaline pH of the insect midgut, has appeared in NEET 2015, in multiple post-2015 papers, and in virtually every major mock test series from ALLEN, Aakash and PW. Write it on a sticky note. Put it on your desk. The question always appears in a form where the wrong answer says acidic pH and the correct answer says alkaline pH. There are no exceptions.
Tip 3: Build a Dedicated Two-Page Summary for the Applications Chapter
The Applications chapter (Chapter 12) is shorter than the Principles chapter but generates more NEET questions in recent years. Its content is entirely factual: names, years, organisms, mechanisms and outcomes. Build a two-page handwritten summary with all the facts in this guide. Organise it as: Medicine applications (insulin, gene therapy, PCR, ELISA, hepatitis B vaccine), Agriculture applications (Bt crops, RNAi, Golden Rice), Transgenic animals (Rosie, sheep, oncomouse, mice), Ethics (GEAC, turmeric, neem, basmati). Revise this two-page summary every 4 to 5 days in the final month before NEET.
Tip 4: Solve the Cry Gene Specificity Table Until It Is Automatic
The cry gene to pest to crop mapping has generated questions in 2022 and is likely to generate questions in 2026. The table has five rows. Write it five times from memory in one sitting. Then close the book and write it again the next morning. This table takes 10 minutes to memorise and secures one mark that most students drop.
Tip 5: Use the Rosie-Sheep Distinction as a Checklist Item
Every time you revise transgenic animals, pause on Rosie and write: Rosie = cow = alpha-lactalbumin = infant nutrition. Then write: Sheep = alpha-1-antitrypsin = emphysema. These two facts are always tested as a pair, either in assertion-reason format or in matching questions. Students who know one but not both in context get assertion-reason questions wrong because the reason cites the wrong animal.
Tip 6: Read the Ethics Section Slowly, Not Quickly
Most students sprint through biopiracy and GEAC because it feels like general knowledge rather than science. This is a strategic error. The questions from this section are easy, direct and factual. The turmeric patent was granted in 1995 and revoked in 1997. The neem case was at the European Patent Office. Basmati was at the US Patent and Trademark Office. GEAC is under the Ministry of Environment. These four facts are each independently testable and collectively secure one mark from the easiest sub-topic in the chapter. Read this section slowly once, write the facts in your notebook, and revise them twice before NEET.
Frequently Asked Questions: Biotechnology and Its Applications NEET 2026
How many questions come from Biotechnology in NEET every year?
The Biotechnology unit, covering both Chapter 11 (Principles and Processes) and Chapter 12 (Applications), contributes 7 to 11 questions per year to NEET. The average across the last seven years is 7.9 questions, which equals approximately 31 marks. In peak years like 2021 and 2022, this unit gave 11 and 10 questions respectively, contributing 44 and 40 marks. No other single unit in Class 12 Biology shows this level of year-on-year consistency in question count.
What is the most important topic in Biotechnology for NEET 2026?
Restriction enzymes are the most frequently tested topic from the Principles chapter, with 24 questions from 2008 to 2025. Bt crops and Cry proteins are the most tested from the Applications chapter, with 18 questions in the same period. Together, these two sub-topics have contributed 42 questions across 17 years. If you have limited revision time, start here and build outward.
How does Bt cotton protect against insects?
Bt cotton plants contain cry genes from Bacillus thuringiensis integrated into their genome. These genes cause the plant to produce Cry proteins in all tissues. When a cotton bollworm or American bollworm feeds on the plant, it ingests Cry pro-toxin crystals. The alkaline pH of the insect’s midgut dissolves the crystal and activates the toxin. The active Cry protein binds to receptor proteins on the insect’s midgut epithelial cells, creates pores, disrupts ion balance, causes cell swelling and death of the gut lining, and the insect dies. The toxin is harmless to humans because the human gut pH does not activate it and human intestinal cells lack the specific receptor.
What is ADA deficiency and why is it so important for NEET?
ADA deficiency is a genetic disorder caused by the absence of the enzyme adenosine deaminase, which is essential for purine metabolism. Its absence causes toxic accumulation of deoxyadenosine in lymphocytes, destroying the immune system and causing Severe Combined Immunodeficiency (SCID). It was the target of the world’s first clinical gene therapy trial in 1990, where a 4-year-old girl was treated using lymphocytes with a functional ADA gene delivered by retroviral vector. NEET tests the year (1990), the patient (4-year-old girl), the disease (ADA deficiency), the vector (retroviral), and the reason the treatment is not permanent (lymphocytes are non-renewing).
Is NCERT enough for Biotechnology in NEET?
Yes, NCERT covers 95 to 98 percent of all NEET Biotechnology questions. Every PYQ analysed in this guide traces back to a specific NCERT line, table or diagram. The remaining 2 to 5 percent of questions test reasoning about NCERT concepts in new situations, which requires understanding rather than additional material. Read NCERT Chapters 11 and 12 three times minimum: once for understanding, once for marking key facts, and once in the final week for rapid revision.
What are examples of biopiracy for NEET?
The three biopiracy examples tested in NEET are the turmeric case (US patent for wound healing, granted 1995, revoked 1997 after CSIR challenge), the neem case (European Patent Office patent for fungicidal use, revoked 2000), and the basmati case (US patent for Basmati rice characteristics granted to RiceTec in 1997, most claims cancelled after India’s challenge). All three involve use of India’s traditional biological knowledge for commercial patents without compensation to Indian communities.
What is the role of GEAC in biotechnology regulation in India?
GEAC stands for Genetic Engineering Appraisal Committee. It functions under the Ministry of Environment, Forest and Climate Change, Government of India. It is responsible for approving the environmental release of genetically modified organisms for large-scale use and commercial cultivation. GEAC approved Bt cotton for commercial release in India in 2002 and placed a moratorium on commercial Bt Brinjal release in 2010 pending further biosafety review.
What are transgenic animals and which type is most common in NEET?
Transgenic animals are organisms that carry a foreign gene (transgene) from another organism stably integrated into their genome. The transgene was introduced at the embryonic stage and is present in every cell of the animal. Transgenic animals are used for studying gene function, disease modelling, producing biological medicines (like alpha-lactalbumin and alpha-1-antitrypsin in milk), vaccine safety testing and chemical toxicity testing. Mice are the most common transgenic animals used worldwide, which NEET 2011 tested directly.
Biotechnology and Its Applications NEET 2026: Your 7-Day Action Plan
You now have every concept, every PYQ pattern and every common mistake from the Biotechnology unit in one place. The question is not whether the content is here. It is whether you execute the revision correctly. Here is the exact 7-day plan that converts this guide into marks.
Day 1: Read Stage 1 of this guide (Recombinant DNA tools) with your NCERT Chapter 11 open. Mark every line in NCERT that corresponds to a NEET PYQ from the table in this guide.
Day 2: Read Stage 2 (Medicine applications) and write the five medicine application facts in your notebook: insulin (Eli Lilly, E. coli, 1982, two chains, synthetic genes), gene therapy (1990, ADA deficiency, 4-year-old girl, retroviral vector, not permanent), PCR (HIV window period), ELISA (antigen-antibody, post-window), Hepatitis B (yeast, second-generation).
Day 3: Read Stage 3 (Agriculture, transgenic animals, ethics) and build the two-page handwritten summary described in Topper Tip 3.
Day 4: Solve all 15 MCQs from Stage 4 of this guide without looking at answers. Score yourself. Every wrong answer goes into your exceptions notebook with the correct explanation.
Day 5: Revise your exceptions notebook entries only. Do not re-read the full guide. Fix what is broken in your understanding, not what is already correct.
Day 6: Do 30 minutes of official NEET PYQs from this chapter using the year-wise table as your checklist. Find the original question for every entry in that table and verify your answer before reading the solution.
Day 7: Re-read your two-page handwritten summary from Day 3. Re-read your exceptions notebook. Do not add new content on Day 7. Consolidate what is already there.
Three revisions of this 7-day cycle before NEET 2026 will position you to score 28 to 36 marks from the Biotechnology unit with high reliability.
Explore More Expert Biology Guides:
-
Cell Biology for NEET 2026: Complete Chapter Guide with PYQs (Blog 1)
-
Molecular Basis of Inheritance NEET 2026: DNA Replication to Gene Expression Decoded
-
Human Health and Diseases NEET 2026: Immunity, Pathogens and Complete Chapter Notes
-
Ecology and Environment NEET 2026: All Concepts, All PYQs, Zero Confusion
-
Genetics and Evolution NEET 2026: Mendelian to Hardy-Weinberg Complete Guide
